Skip to main content
. 2002 Apr;53(4):355–362. doi: 10.1046/j.1365-2125.2002.01158.x

Table 1.

Overview of reported adverse events in the two studies.

Study A Study B
Tezosentan Placebo Tezosentan Placebo
Number of subjects 6 2 8 4
Number of subjects reporting adverse events 6 1 6 2
Total number of adverse events reported 11 2 9 4
Specific adverse events reported (number of cases)
 Headache 6 1 6 2
 Flushing 1 1
 Nausea 1
 Abdominal pain 1
 Dizziness 1
 Palpitations 1
 Haematoma 1
 Eye pain 1 1
 Back pain 1 1